Delivery Order SPE2DB20D2014-SPE2DB25FD11F
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 26, 2025, for the supply of Fluticasone Propionate 50 mcg spray in 16 gram units, with a ceiling value of $1,682.80 and a firm fixed price structure. This delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by June 27, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Fluticasone Prop 50 MCG Spray 16GM, with a contract value of $2,105.64. The award, issued on September 15, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 16, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,708.50 by the Defense Logistics Agency on August 12, 2025, for Fluticasone Propionate 50 micrograms spray in 16-gram units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for Fluticasone Propionate 50 MCG Spray in 16GM units, with a ceiling value of $1,452.36. This competitively awarded, firm fixed-price delivery order, which is non-set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and is scheduled for completion by September 12, 2025. As a child contract action, this delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for the supply of Fluticasone Propionate 50 MCG Spray in 16GM units, with a ceiling value of $1,730.88. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,390.46 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,365.73 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical supply transaction executed under the company's existing contract vehicle with DLA. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for Fluticasone Propionate 50 micrograms spray in a 16-gram formulation, with a ceiling value of $1,736.20. This firm fixed-price delivery order, due for completion by September 22, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms spray (16-gram unit) valued at $1,396.90 under a firm fixed-price contract type. This delivery order, issued on August 19, 2025, represents a non-competitive set-aside and carries an ultimate completion date of August 20, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- AmerisourceBergen Drug Corp was awarded a $3,941.38 delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers (12 grams). The contract is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured....
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD11FDelivery Order
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 25, 2025, for Fluticasone Propionate 50 MCG Spray in 16GM units, with a ceiling value of $6,220.80. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 26, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains a broad portfolio of medications and medical supplies supporting military and veteran healthcare systems. The current delivery order for this respiratory medication reflects the company's ongoing role in supplying critical pharmaceutical products through the DLA's Medical Supply Chain to support Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/25/25 |